XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows from Operating Activities    
Net income $ 65,017 $ 54,121
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 15,808 14,799
Noncash long-term incentive compensation 9,106 2,024
Stock option expense 9,025 8,482
Benefit for deferred income taxes (5,422) (3,195)
Amortization of debt issuance costs 80 95
Changes in operating assets and liabilities:    
Decrease/(increase) in accounts receivable 5,345 (14,318)
Decrease/(increase) in inventories 1,302 (391)
Decrease in prepaid expenses 1,909 1,236
Decrease in accounts payable and other current liabilities (43,012) (24,109)
Change in current income taxes 23,871 19,118
Net change in lease assets and liabilities 25 (632)
Increase in other assets (12,243) (2,173)
Increase in other liabilities 13,332 5,313
Other sources 406 122
Net cash provided by operating activities 84,549 60,492
Cash Flows from Investing Activities    
Capital expenditures (12,163) (17,020)
Business combinations, net of cash acquired (7,300)  
Proceeds from sale of fixed assets 86 146
Other uses (8) (139)
Net cash used by investing activities (19,385) (17,013)
Cash Flows from Financing Activities    
Purchases of treasury stock (38,460)  
Proceeds from exercise of stock options 37,242 25,680
Dividends paid (6,050) (5,685)
Capital stock surrendered to pay taxes on stock-based compensation (5,725) (3,166)
Change in cash overdrafts payable (2,115)  
Payments on other long-term debt   (76,250)
Other uses (664) (130)
Net cash used by financing activities (15,772) (59,551)
Increase/(Decrease) in Cash and Cash Equivalents 49,392 (16,072)
Cash and cash equivalents at beginning of period 263,958 74,126
Cash and cash equivalents at end of period $ 313,350 $ 58,054